EXAS: Exact Sciences Corporation Stocks News on June 1, 2025

Exact Sciences Announces Expanded Clinical Validation of the Oncodetect™ Test and Molecular Residual Disease Innovation Roadmap

EXAS

Business Wire

4 days ago

Exact Sciences Announces Expanded Clinical Validation of the Oncodetect™ Test and Molecular Residual Disease Innovation Roadmap

Exact Sciences to Participate in June Investor Conference

EXAS

Business Wire

5 days ago

Exact Sciences to Participate in June Investor Conference

3 Low-Volatility Stocks Walking a Fine Line

EXAS

StockStory

9 days ago

3 Low-Volatility Stocks Walking a Fine Line

Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025

EXAS

Business Wire

10 days ago

Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025

EXAS

Insider Monkey

12 days ago

Exact Sciences Corporation (EXAS) Slid on Fear of Competition

EXAS

Morningstar Research

12 days ago

Analyst Report: Exact Sciences Corporation

EXAS

StockStory

16 days ago

EXAS Q1 Earnings Call: Outperformance Driven by Commercial Execution, New Products, and Margin Expansion

1 Healthcare Stock Worth Investigating and 2 to Ignore

EXAS

StockStory

16 days ago

1 Healthcare Stock Worth Investigating and 2 to Ignore

2 Brilliant Stocks to Buy With $200 and Hold for 5 Years

EXAS

Motley Fool

18 days ago

2 Brilliant Stocks to Buy With $200 and Hold for 5 Years

Exact Sciences Earns 2025 Great Place To Work® Certification™

EXAS

Business Wire

20 days ago

Exact Sciences Earns 2025 Great Place To Work® Certification™

What To Expect From Natera’s (NTRA) Q1 Earnings

EXAS

StockStory

25 days ago

What To Expect From Natera’s (NTRA) Q1 Earnings

EXAS

Morningstar Research

a month ago

Analyst Report: Exact Sciences Corporation

EXAS

Simply Wall St.

a month ago

Analysts Have Made A Financial Statement On Exact Sciences Corporation's (NASDAQ:EXAS) First-Quarter Report

Exact Sciences First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

EXAS

Simply Wall St.

a month ago

Exact Sciences First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

EXAS

Thomson Reuters StreetEvents

a month ago

Q1 2025 Exact Sciences Corp Earnings Call

EXAS

StockStory

a month ago

Exact Sciences (EXAS) Stock Trades Up, Here Is Why

EXAS

MT Newswires

a month ago

RBC Raises Price Target on Exact Sciences to $54 From $52, Keeps Sector Perform Rating

EXAS

Zacks

a month ago

EXAS Stock Up on Q1 Earnings & Revenue Beat, 2025 Sales View Raised

Exact Sciences to Participate in May Investor Conference

EXAS

Business Wire

a month ago

Exact Sciences to Participate in May Investor Conference

EXAS

GuruFocus.com

a month ago

Exact Sciences Corp (EXAS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and New ...

EXAS

StockStory

a month ago

Exact Sciences (NASDAQ:EXAS) Posts Better-Than-Expected Sales In Q1, Stock Soars

EXAS

Zacks

a month ago

Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates

EXAS

Associated Press Finance

a month ago

Exact Sciences: Q1 Earnings Snapshot

Exact Sciences Hikes Its Full-Year Outlook. But There's One First-Quarter Drawback.

EXAS

Investor's Business Daily

a month ago

Exact Sciences Hikes Its Full-Year Outlook. But There's One First-Quarter Drawback.

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

EXAS

Zacks

a month ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

EXAS

StockStory

a month ago

Exact Sciences (EXAS) Reports Q1: Everything You Need To Know Ahead Of Earnings

EXAS

Simply Wall St.

a month ago

US High Growth Tech Stocks to Watch

Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025

EXAS

Business Wire

a month ago

Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025

Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy?

EXAS

Zacks

a month ago

Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy?

This Exact Sciences Insider Increased Their Holding In The Last Year

EXAS

Simply Wall St.

a month ago

This Exact Sciences Insider Increased Their Holding In The Last Year

EXAS

Zacks

a month ago

Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

EXAS

Insider Monkey

a month ago

Exact Sciences (EXAS): Among Billionaire George Soros’ Small-Cap Stocks with Huge Upside Potential

EXAS

StockStory

a month ago

2 Reasons to Like EXAS (and 1 Not So Much)

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

EXAS

Zacks

a month ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test

EXAS

Business Wire

a month ago

Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.

EXAS

Investor's Business Daily

a month ago

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.

EXAS

StockStory

2 months ago

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

Tap Into the Silver Economy Boom With These Aging Demographics Stocks

EXAS

Zacks

2 months ago

Tap Into the Silver Economy Boom With These Aging Demographics Stocks

JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups

EXAS

Business Wire

2 months ago

JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups

Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

EXAS

StockStory

2 months ago

Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

2 Oversold Stocks Ready to Bounce Back and 1 to Approach with Caution

EXAS

StockStory

2 months ago

2 Oversold Stocks Ready to Bounce Back and 1 to Approach with Caution

EXAS

MT Newswires

2 months ago

Mizuho Initiates Exact Sciences at Outperform With $60 Price Target

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

EXAS

StockStory

2 months ago

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

Exact Sciences Schedules First Quarter 2025 Earnings Call

EXAS

Business Wire

2 months ago

Exact Sciences Schedules First Quarter 2025 Earnings Call

Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening

EXAS

Business Wire

2 months ago

Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening

High Growth Tech Stocks To Watch In The US March 2025

EXAS

Simply Wall St.

2 months ago

High Growth Tech Stocks To Watch In The US March 2025

Should You Retain Exact Sciences Stock in Your Portfolio Now?

EXAS

Zacks

2 months ago

Should You Retain Exact Sciences Stock in Your Portfolio Now?

2 Small-Cap Stocks on Our Watchlist and 1 to Ignore

EXAS

StockStory

2 months ago

2 Small-Cap Stocks on Our Watchlist and 1 to Ignore

EXAS

Insider Monkey

2 months ago

Why Exact Sciences Corporation (EXAS) is Among the Best Diagnostics Stocks to Invest in Right Now

EXAS

Zacks

2 months ago

Exact Sciences (EXAS) Down 10.6% Since Last Earnings Report: Can It Rebound?

1 Healthcare Stock on Our Watchlist and 2 to Turn Down

EXAS

StockStory

2 months ago

1 Healthcare Stock on Our Watchlist and 2 to Turn Down

EXAS

Insider Monkey

2 months ago

Should You Invest in Exact Sciences Corp. (EXAS)?

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack

EXAS

StockStory

2 months ago

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN

EXAS

PR Newswire

2 months ago

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN

1 Stock Under $50 to Target This Week and 2 to Turn Down

EXAS

StockStory

3 months ago

1 Stock Under $50 to Target This Week and 2 to Turn Down

EXAS

MT Newswires

3 months ago

RBC Initiates Exact Sciences at Sector Perform With $52 Price Target

Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner

EXAS

Business Wire

3 months ago

Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner

3 Top Cancer Biotechs to Keep An Eye On in 2025

EXAS

Zacks

3 months ago

3 Top Cancer Biotechs to Keep An Eye On in 2025

EXAS

Insider Monkey

3 months ago

Here’s What Led Artisan Mid Cap Fund to Trim Exact Sciences Corporation (EXAS)

EXAS

Insider Monkey

3 months ago

Exact Sciences Corporation (EXAS): Among the Cash-Rich Mid Cap Stocks to Buy Now

Exploring Three High Growth Tech Stocks In The United States

EXAS

Simply Wall St.

3 months ago

Exploring Three High Growth Tech Stocks In The United States

2 Stocks Down 59% and 34% to Buy and Hold

EXAS

Motley Fool

3 months ago

2 Stocks Down 59% and 34% to Buy and Hold

Exact Sciences to Participate in March Investor Conferences

EXAS

Business Wire

3 months ago

Exact Sciences to Participate in March Investor Conferences

Exact Sciences Full Year 2024 Earnings: EPS Misses Expectations

EXAS

Simply Wall St.

3 months ago

Exact Sciences Full Year 2024 Earnings: EPS Misses Expectations

EXAS

Morningstar Research

3 months ago

Analyst Report: Exact Sciences Corporation

EXAS

StockStory

3 months ago

Why Exact Sciences (EXAS) Shares Are Trading Lower Today

EXAS

Thomson Reuters StreetEvents

3 months ago

Q4 2024 Exact Sciences Corp Earnings Call

EXAS

Zacks

3 months ago

EXAS Q4 Loss Narrower Than Expected, Stock Falls, Revenues Up Y/Y

EXAS

GuruFocus.com

3 months ago

Exact Sciences Corp (EXAS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

EXAS

Motley Fool

3 months ago

Exact Sciences (EXAS) Q4 2024 Earnings Call Transcript

EXAS

Zacks

3 months ago

Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates

EXAS

Associated Press Finance

3 months ago

Exact Sciences: Q4 Earnings Snapshot

EXAS

StockStory

3 months ago

Exact Sciences’s (NASDAQ:EXAS) Q4: Beats On Revenue

Exact Sciences Announces Fourth Quarter 2024 Results

EXAS

Business Wire

3 months ago

Exact Sciences Announces Fourth Quarter 2024 Results

EXAS

StockStory

3 months ago

Exact Sciences (EXAS) Reports Earnings Tomorrow: What To Expect

Guardant Health (GH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

EXAS

Zacks

4 months ago

Guardant Health (GH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

EXAS

Zacks

4 months ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Trickle-down effect of NIH funding battle worries healthcare analysts and medical experts

EXAS

Yahoo Finance

4 months ago

Trickle-down effect of NIH funding battle worries healthcare analysts and medical experts

EXAS

Zacks

4 months ago

Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

EXAS

Simply Wall St.

4 months ago

When Can We Expect A Profit From Exact Sciences Corporation (NASDAQ:EXAS)?

Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members

EXAS

GlobeNewswire

4 months ago

Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members

Exact Sciences Schedules Fourth Quarter 2024 Earnings Call

EXAS

Business Wire

4 months ago

Exact Sciences Schedules Fourth Quarter 2024 Earnings Call

EXAS

Zacks

4 months ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

EXAS

MT Newswires

4 months ago

Barclays Initiates Exact Sciences at Overweight

Exact Sciences post positive results from MRD trial

EXAS

Clinical Trials Arena

4 months ago

Exact Sciences post positive results from MRD trial

New Evidence Validates Oncodetect's™ Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients

EXAS

Business Wire

4 months ago

New Evidence Validates Oncodetect's™ Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients

Exact Sciences Demonstrates Leadership in Cancer Innovation with New Data on Screening and Molecular Residual Disease at 2025 ASCO GI Symposium

EXAS

Business Wire

4 months ago

Exact Sciences Demonstrates Leadership in Cancer Innovation with New Data on Screening and Molecular Residual Disease at 2025 ASCO GI Symposium

Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone

EXAS

Investor's Business Daily

4 months ago

Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone

EXAS

Insider Monkey

4 months ago

Why Exact Sciences (EXAS) Is Crashing?

EXAS

Morningstar Research

4 months ago

Analyst Report: Exact Sciences Corporation

Exact Sciences Stock Drops 11% Over Four Days. 'What Is Going On?'

EXAS

Investor's Business Daily

5 months ago

Exact Sciences Stock Drops 11% Over Four Days. 'What Is Going On?'

2 Healthcare Stocks to Buy Hand Over Fist in January

EXAS

Motley Fool

5 months ago

2 Healthcare Stocks to Buy Hand Over Fist in January

High Growth Tech Stocks To Watch In January 2025

EXAS

Simply Wall St.

5 months ago

High Growth Tech Stocks To Watch In January 2025

EXAS

MT Newswires

5 months ago

Exact Sciences Expects 10% Growth in Q4 Revenue

Exact Sciences Announces Preliminary Fourth Quarter 2024 Results

EXAS

Business Wire

5 months ago

Exact Sciences Announces Preliminary Fourth Quarter 2024 Results

Should Exact Sciences Stock Stay in Your Portfolio Right Now?

EXAS

Zacks

5 months ago

Should Exact Sciences Stock Stay in Your Portfolio Right Now?

Exact Sciences price target raised to $70 from $60 at Evercore ISI

EXAS

TipRanks

5 months ago

Exact Sciences price target raised to $70 from $60 at Evercore ISI

Exact Sciences to Participate in J.P. Morgan Healthcare Conference

EXAS

Business Wire

5 months ago

Exact Sciences to Participate in J.P. Morgan Healthcare Conference

Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report?

EXAS

Zacks

6 months ago

Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report?

Pacira (PCRX) Up 5.5% Since Last Earnings Report: Can It Continue?

EXAS

Zacks

6 months ago

Latest Exact Sciences Corporation (EXAS) News on June 1, 2025

Share on Social Networks: